Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Sep;46(3):392–396. doi: 10.1038/bjc.1982.215

Vindesine receptors in cells of a human leukaemia cell line.

K Totsuka, K Oshimi, H Mizoguchi
PMCID: PMC2011119  PMID: 6957239

Abstract

To determine whether vindesine receptors are present in human leukaemic cells, K562 cells (established from chronic myelogenous leukaemia in blastic crisis) were incubated with 3H-vindesine. Binding of 3H-vindesine increased with incubation time and with increase in number of K562 cells. However, when excessive amounts of nonradioactive vindesine were added, the 3H-vindesine was displaced. Binding of 3H-vindesine was only inhibited by vinblastine, vincristine and vindesine. These results suggest that K562 cells have receptors for vindesine and that these receptors are common to vinca alkaloids. Scatchard analysis showed that the number of vindesine receptors differed according to the kind of cells tested. K562 and a T-cell leukaemia-derived cell line, MOLT-4, had more receptors than an acute promyelocytic leukaemia-derived cell line, HL-60, and normal blood lymphocytes. The degree of vindesine affinity to receptors did not differ markedly among the above-mentioned cells.

Full text

PDF
392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CUTTS J. H. The effect of vincaleukoblastine on dividing cells in vivo. Cancer Res. 1961 Feb;21:168–172. [PubMed] [Google Scholar]
  2. Chirife A. M., Studzinski G. P. Definition of the cell cycle segment with special sensitivity to vinblastine. Proc Soc Exp Biol Med. 1978 Feb;157(2):206–210. doi: 10.3181/00379727-157-40022. [DOI] [PubMed] [Google Scholar]
  3. Gout P. W., Wijcik L. L., Beer C. T. Differences between vinblastine and vincristine in distribution in the blood of rats and binding by platelets and malignant cells. Eur J Cancer. 1978 Nov;14(11):1167–1178. doi: 10.1016/0014-2964(78)90222-0. [DOI] [PubMed] [Google Scholar]
  4. Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
  5. Marantz R., Ventilla M., Shelanski M. Vinblastine-induced precipitation of microtubule protein. Science. 1969 Aug 1;165(3892):498–499. doi: 10.1126/science.165.3892.498. [DOI] [PubMed] [Google Scholar]
  6. McGuire W. L. Current status of estrogen receptors in human breast cancer. Cancer. 1975 Aug;36(2):638–644. doi: 10.1002/1097-0142(197508)36:2+<638::aid-cncr2820360805>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  7. Miller T. P., Jones S. E., Chester A. B., Dorr R. T. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions. Cancer Treat Rev. 1980 Sep;7 (Suppl 1):81–86. doi: 10.1016/s0305-7372(80)80013-2. [DOI] [PubMed] [Google Scholar]
  8. Owellen R. J., Donigian D. W., Hartke C. A., Dickerson R. M., Kuhar M. J. The binding of vinblastine to tubulin and to particulate fractions of mammalian brain. Cancer Res. 1974 Dec;34(12):3180–3186. [PubMed] [Google Scholar]
  9. Owellen R. J., Donigian D. W., Hartke C. A., Hains F. O. Correlation of biologic data with physico-chemical properties among the vinca alkaloids and their congeners. Biochem Pharmacol. 1977 Jul 1;26(13):1213–1219. doi: 10.1016/0006-2952(77)90108-3. [DOI] [PubMed] [Google Scholar]
  10. Owellen R. J., Owens A. H., Jr, Donigian D. W. The binding of vincristine, vinblastine and colchicine to tubulin. Biochem Biophys Res Commun. 1972 May 26;47(4):685–691. doi: 10.1016/0006-291x(72)90546-3. [DOI] [PubMed] [Google Scholar]
  11. PALMER C. G., LIVENGOOD D., WARREN A. K., SIMPSON P. J., JOHNSON I. S. The action of the vincaleukolastine on mitosis in vitro. Exp Cell Res. 1960 Jun;20:198–201. doi: 10.1016/0014-4827(60)90234-2. [DOI] [PubMed] [Google Scholar]
  12. Secret C. J., Hadfield J. R., Beer C. T. Studies on the binding of ( 3 H)vinblastine by rat blood platelets in vitro. Effects of colchicine and vincristine. Biochem Pharmacol. 1972 Jun 1;21(11):1609–1624. doi: 10.1016/0006-2952(72)90311-5. [DOI] [PubMed] [Google Scholar]
  13. Stambaugh J. E., Jr Phase II trial of vindesine in advanced neoplastic disease. Cancer Treat Rev. 1980 Sep;7 (Suppl 1):75–79. doi: 10.1016/s0305-7372(80)80012-0. [DOI] [PubMed] [Google Scholar]
  14. Wilson L., Bamburg J. R., Mizel S. B., Grisham L. M., Creswell K. M. Interaction of drugs with microtubule proteins. Fed Proc. 1974 Feb;33(2):158–166. [PubMed] [Google Scholar]
  15. Young C. W. Vindesine trials at Memorial Sloan-Kettering Cancer Center. Cancer Treat Rev. 1980 Sep;7 (Suppl 1):53–57. doi: 10.1016/s0305-7372(80)80008-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES